These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Raynaud's phenomenon: a common toxicity after combination chemotherapy for testicular cancer. Vogelzang NJ; Bosl GJ; Johnson K; Kennedy BJ Ann Intern Med; 1981 Sep; 95(3):288-92. PubMed ID: 6168223 [TBL] [Abstract][Full Text] [Related]
5. Raynaud's phenomenon and cancer chemotherapy. Scheulen ME; Schmidt CG Ann Intern Med; 1982 Feb; 96(2):256-7. PubMed ID: 6174061 [No Abstract] [Full Text] [Related]
6. Raynaud's phenomenon after vinblastine-bleomycin chemotherapy. Rothberg H; Varney JK J Med Soc N J; 1978 Nov; 75(12):845-6. PubMed ID: 81878 [No Abstract] [Full Text] [Related]
7. Raynaud's phenomenon as a side effect of chemotherapy with vinblastine and bleomycin for testicular carcinoma. Teutsch C; Lipton A; Harvey HA Cancer Treat Rep; 1977 Aug; 61(5):925-6. PubMed ID: 70274 [No Abstract] [Full Text] [Related]
8. Cancer chemotherapy and Raynaud's phenomenon. Grau JJ; Grau M; Millá A; Estapé J; Mulet M Ann Intern Med; 1983 Feb; 98(2):258. PubMed ID: 6186172 [No Abstract] [Full Text] [Related]
10. [Raynaud's disease after treatment with bleomycin and vinblastine]. Dzieza-Lalowicz I; Mykała-Cieśla J Pol Tyg Lek; 1986 Feb; 41(7):218-9. PubMed ID: 2423995 [No Abstract] [Full Text] [Related]
11. Raynaud's phenomenon and cryoglobulinemia during chemotherapy for testicular carcinoma. Dunlop PR; Hendy-Ibbs PM Cancer Treat Rep; 1983 Mar; 67(3):317-8. PubMed ID: 6187453 [No Abstract] [Full Text] [Related]
12. Raynaud's phenomenon after vinblastine-bleomycin chemotherapy. Rothberg H Cancer Treat Rep; 1978 Apr; 62(4):569-70. PubMed ID: 77726 [No Abstract] [Full Text] [Related]
13. Chemotherapy-associated Raynaud's phenomenon in a two-year-old girl. McGuire WA; Passo MH; Weetman RM Med Pediatr Oncol; 1985; 13(6):392-4. PubMed ID: 2413340 [TBL] [Abstract][Full Text] [Related]
14. Raynaud's phenomenon and acral necrosis after chemotherapy for AIDS-related Kaposi's sarcoma. Reiser M; Bruns C; Hartmann P; Salzberger B; Diehl V; Fätkenheuer G Eur J Clin Microbiol Infect Dis; 1998 Jan; 17(1):58-60. PubMed ID: 9512187 [TBL] [Abstract][Full Text] [Related]
15. Hypomagnesemia, renal dysfunction, and Raynaud's phenomenon in patients treated with cisplatin, vinblastine, and bleomycin. Vogelzang NJ; Torkelson JL; Kennedy BJ Cancer; 1985 Dec; 56(12):2765-70. PubMed ID: 2413982 [TBL] [Abstract][Full Text] [Related]
16. Raynaud's phenomenon and digital gangrene as a consequence of treatment for Kaposi's sarcoma. Hladunewich M; Sawka C; Fam A; Franssen E J Rheumatol; 1997 Dec; 24(12):2371-5. PubMed ID: 9415644 [TBL] [Abstract][Full Text] [Related]
17. [Raynaud's phenomenon and finger necrosis after treatment of ovarian seminoma with bleomycin, vinblastine and 5-fluorouracil]. Werquin S; Kacet S; Caron J; Lacroix D; Libersa C; Coget JM; Lekieffre J Ann Cardiol Angeiol (Paris); 1987 Oct; 36(8):409-12. PubMed ID: 2445238 [TBL] [Abstract][Full Text] [Related]
18. [Raynaud's phenomenon after chemotherapy. Apropos of 3 cases]. Adoue D; Arlet P; Vilain C; Le Tallec Y; Bonafé JL; de Lafontan B Ann Dermatol Venereol; 1985; 112(2):151-5. PubMed ID: 2408534 [TBL] [Abstract][Full Text] [Related]